PharmChem, Inc.
PCHM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14,215 | $12,925 | $10,145 | $28,259 |
| - Cash | $1,629 | $1,572 | $3,283 | $2,217 |
| + Debt | $51 | $77 | $0 | $0 |
| Enterprise Value | $12,636 | $11,431 | $6,862 | $26,041 |
| Revenue | $6,085 | $6,012 | $5,837 | $6,220 |
| % Growth | 1.2% | 3% | -6.2% | – |
| Gross Profit | $3,877 | $3,904 | $3,746 | $3,891 |
| % Margin | 63.7% | 64.9% | 64.2% | 62.5% |
| EBITDA | $1,741 | $1,054 | $1,106 | $1,673 |
| % Margin | 28.6% | 17.5% | 19% | 26.9% |
| Net Income | $1,381 | $845 | $870 | $1,852 |
| % Margin | 22.7% | 14.1% | 14.9% | 29.8% |
| EPS Diluted | 0.3 | 0.17 | 0.16 | 0.28 |
| % Growth | 76.5% | 6.3% | -42.9% | – |
| Operating Cash Flow | $1,305 | $639 | $1,266 | $875 |
| Capital Expenditures | -$3 | -$0 | $0 | $0 |
| Free Cash Flow | $1,303 | $639 | $1,266 | $875 |